Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Overview of the IL‐1 family in innate inflammation and acquired immunity
Charles A. Dinarello
Immunological Reviews (2017) Vol. 281, Iss. 1, pp. 8-27
Open Access | Times Cited: 1435

Showing 1-25 of 1435 citing articles:

Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
Lorenzo Galluzzi, Ilio Vitale, Sarah H. Warren, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 1, pp. e000337-e000337
Open Access | Times Cited: 838
Interleukin-1 and Related Cytokines in the Regulation of Inflammation and Immunity
Alberto Mantovani, Charles A. Dinarello, Martina Molgora, et al.
Immunity (2019) Vol. 50, Iss. 4, pp. 778-795
Open Access | Times Cited: 836
NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis
Alena Grebe, Florian Hoß, Eicke Latz
Circulation Research (2018) Vol. 122, Iss. 12, pp. 1722-1740
Open Access | Times Cited: 713
An Update on Current Therapeutic Drugs Treating COVID-19
Renyi Wu, Lujing Wang, Hsiao‐Chen Dina Kuo, et al.
Current Pharmacology Reports (2020) Vol. 6, Iss. 3, pp. 56-70
Open Access | Times Cited: 600
The Immunology of Macrophage Activation Syndrome
Courtney B. Crayne, Sabrin Albeituni, Kim E. Nichols, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 558
Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
Antonio Abbate, Stefano Toldo, Carlo Marchetti, et al.
Circulation Research (2020) Vol. 126, Iss. 9, pp. 1260-1280
Open Access | Times Cited: 545
The cytokine network involved in the host immune response to periodontitis
Weiyi Pan, Qingxuan Wang, Qianming Chen
International Journal of Oral Science (2019) Vol. 11, Iss. 3
Open Access | Times Cited: 526
COVID-19 infection: an overview on cytokine storm and related interventions
Soheila Montazersaheb, Seyed Mahdi Hosseiniyan Khatibi, Mohammad Saeid Hejazi, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 455
Next generation of immune checkpoint inhibitors and beyond
Julian A. Marin‐Acevedo, ErinMarie O. Kimbrough, Yanyan Lou
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 446
The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory
Sonia Ndeupen, Zhen Qin, Sonya Jacobsen, et al.
iScience (2021) Vol. 24, Iss. 12, pp. 103479-103479
Open Access | Times Cited: 391
Blocking IL-1β reverses the immunosuppression in mouse breast cancer and synergizes with anti–PD-1 for tumor abrogation
Irena Kaplanov, Yaron Carmi, Rachel Kornetsky, et al.
Proceedings of the National Academy of Sciences (2018) Vol. 116, Iss. 4, pp. 1361-1369
Open Access | Times Cited: 370
Pyroptosis in inflammatory diseases and cancer
Zhiping Rao, Yutong Zhu, Peng Yang, et al.
Theranostics (2022) Vol. 12, Iss. 9, pp. 4310-4329
Open Access | Times Cited: 320
Control of gasdermin D oligomerization and pyroptosis by the Ragulator-Rag-mTORC1 pathway
Charles L. Evavold, Iva Hafner‐Bratkovič, Pascal Devant, et al.
Cell (2021) Vol. 184, Iss. 17, pp. 4495-4511.e19
Open Access | Times Cited: 313
The IL-1 family of cytokines and receptors in rheumatic diseases
Charles A. Dinarello
Nature Reviews Rheumatology (2019) Vol. 15, Iss. 10, pp. 612-632
Closed Access | Times Cited: 310
Inflammasome signaling and regulation of interleukin-1 family cytokines
Amy H. Chan, Kate Schroder
The Journal of Experimental Medicine (2019) Vol. 217, Iss. 1
Open Access | Times Cited: 307
Inflammation-related pyroptosis, a novel programmed cell death pathway, and its crosstalk with immune therapy in cancer treatment
Sheng‐Kai Hsu, Chia‐Yang Li, I‐Ling Lin, et al.
Theranostics (2021) Vol. 11, Iss. 18, pp. 8813-8835
Open Access | Times Cited: 306
Inflammatory Cytokines and Chemokines as Therapeutic Targets in Heart Failure
Anis Hanna, Nikolaos G. Frangogiannis
Cardiovascular Drugs and Therapy (2020) Vol. 34, Iss. 6, pp. 849-863
Open Access | Times Cited: 292
Anti-inflammatory Action of Statins in Cardiovascular Disease: the Role of Inflammasome and Toll-Like Receptor Pathways
Khadijeh Koushki, Sanaz Keshavarz Shahbaz, Kazem Mashayekhi, et al.
Clinical Reviews in Allergy & Immunology (2020) Vol. 60, Iss. 2, pp. 175-199
Open Access | Times Cited: 272
Fiery Cell Death: Pyroptosis in the Central Nervous System
Brienne McKenzie, Vishva M. Dixit, Christopher Power
Trends in Neurosciences (2019) Vol. 43, Iss. 1, pp. 55-73
Closed Access | Times Cited: 264
IL-1β and the Intestinal Epithelial Tight Junction Barrier
Lauren W. Kaminsky, Rana Al–Sadi, Y. Thomas
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 262
Structural Basis of IL-1 Family Cytokine Signaling
James K. Fields, Sebastian Günther, Eric J. Sundberg
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 232
The impact of the Fungus-Host-Microbiota interplay uponCandida albicansinfections: current knowledge and new perspectives
Christophe d’Enfert, Ann-Kristin Kaune, Leovigildo-Rey Alaban, et al.
FEMS Microbiology Reviews (2020) Vol. 45, Iss. 3
Open Access | Times Cited: 227
Interleukin 1α: a comprehensive review on the role of IL-1α in the pathogenesis and treatment of autoimmune and inflammatory diseases
Giulio Cavalli, Serena Colafrancesco, Giacomo Emmi, et al.
Autoimmunity Reviews (2021) Vol. 20, Iss. 3, pp. 102763-102763
Open Access | Times Cited: 226
Pyroptosis, metabolism, and tumor immune microenvironment
Tiantian Du, Jie Gao, Peilong Li, et al.
Clinical and Translational Medicine (2021) Vol. 11, Iss. 8
Open Access | Times Cited: 220
Natural history of COVID-19 and current knowledge on treatment therapeutic options
Wagner Gouvêa dos Santos
Biomedicine & Pharmacotherapy (2020) Vol. 129, pp. 110493-110493
Open Access | Times Cited: 212
Page 1 - Next Page

Scroll to top